Immune evasion, infectivity, and fusogenicity of SARS-CoV-2 BA.2.86 and FLip variants
Cell · 2024
DOI: 10.1016/j.cell.2023.12.026 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cell, 2024. Verfasst von Panke Qu und 13 weiteren Autor:innen. Beteiligte Einrichtung: Center for Retrovirus Research, The Ohio State University, Columbus, OH 43210, USA; Department of Veterinary Biosciences, The Ohio State University, …. Hauptthemen laut MEDLINE: COVID-19, COVID-19 Vaccines, Immune Evasion, SARS-CoV-2. Die Arbeit wurde bisher 143-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NCATS NIH HHS, NICHD NIH HHS, NCI NIH HHS.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Center for Retrovirus Research, The Ohio State University, Columbus, OH 43210, USA; Department of Veterinary Biosciences, The Ohio State University, Columbus, OH 43210, USA.
- Center for Retrovirus Research, The Ohio State University, Columbus, OH 43210, USA; Department of Veterinary Biosciences, The Ohio State University, Columbus, OH 43210, USA; Molecular, Cellular, and Developmental Biolog…
- Department of Internal Medicine, Division of Cardiovascular Medicine, The Ohio State University, Columbus, OH 43210, USA.
- Department of Internal Medicine, Division of Pulmonary, Critical Care, and Sleep Medicine, The Ohio State University, Columbus, OH 43210, USA; Dorothy M. Davis Heart and Lung Research Institute, The Ohio State Universit…
- Center for Food Animal Health, Animal Sciences Department, OARDC, College of Food, Agricultural and Environmental Sciences, The Ohio State University, Wooster, OH 44691, USA; Veterinary Preventive Medicine Department, C…
- Department of Microbial Infection and Immunity, The Ohio State University, Columbus, OH 43210, USA; Pelotonia Institute for Immuno-Oncology, The Ohio State University Comprehensive Cancer Center, Columbus, OH 43210, USA.
Förderung
- NCATS NIH HHS
- NICHD NIH HHS
- NCI NIH HHS
Zitieren
APA
Qu, P., Xu, K., Faraone, J. N., Goodarzi, N., Zheng, Y. M., Carlin, C., Bednash, J. S., Horowitz, J. C., Mallampalli, R. K., Saif, L. J., Oltz, E. M., Jones, D., Gumina, R. J., & Liu, S. L. (2024). Immune evasion, infectivity, and fusogenicity of SARS-CoV-2 BA.2.86 and FLip variants. Cell. https://doi.org/10.1016/j.cell.2023.12.026
Vancouver
Qu P, Xu K, Faraone JN, Goodarzi N, Zheng YM, Carlin C, et al. Immune evasion, infectivity, and fusogenicity of SARS-CoV-2 BA.2.86 and FLip variants. Cell. 2024. doi:10.1016/j.cell.2023.12.026
BibTeX
@article{Qu2024,
author = {Qu, Panke and Xu, Kai and Faraone, Julia N and Goodarzi, Negin and Zheng, Yi-Min and Carlin, Claire and Bednash, Joseph S and Horowitz, Jeffrey C and Mallampalli, Rama K and Saif, Linda J and Oltz, Eugene M and Jones, Daniel and Gumina, Richard J and Liu, Shan-Lu},
title = {Immune evasion, infectivity, and fusogenicity of SARS-CoV-2 BA.2.86 and FLip variants},
journal = {Cell},
year = {2024},
doi = {10.1016/j.cell.2023.12.026}
}
EUVIMED